InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.25
(
0.20%
)
US TECH 100
18,971.20
(
-0.03%
)
Dow Jones
40,659.76
(
0.24%
)
Brent Oil
79.17
(
0.00%
)
Bitcoin
59,650.00
(
0.30%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rancherho

Send PM Follow Ignore
Followers 8
Posts 190
Boards Moderated 0
Alias Born 10/30/2005

rancherho

Re: None

Tuesday, 12/11/2007 10:36:50 PM

Tuesday, December 11, 2007 10:36:50 PM

Post# of 12660
Although this is a DNDN MB, there are so may aspects of DNDN's Provenge and CEGE's GVAX that relate to dealing with similar issues (and the CEGE MBs are relatively inactive) that I have posted a summary of relevant clinical activity of CEGE for anyone wanting to keep track of both at:
http://www1.investorvillage.com/smbd.asp?mb=247&mn=227&pt=msg&mid=3649880
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up